{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:22:42Z","timestamp":1760059362219,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Tuberculosis (TB) is one of the most common infectious diseases in developing countries. The resistance of the causative agent, Mycobacterium tuberculosis, to two or more first-line anti-TB drugs results in multidrug-resistant (MDR) TB, posing a serious challenge to the control of TB worldwide. This study was designed to determine the changes in drug resistance over time in TB strains isolated from patients in all departments of Uluda\u011f University Hospital in western T\u00fcrkiye. Materials and Methods: We retrospectively analyzed 104,598 clinical samples sent to our laboratory for the investigation of the presence of TB between 1996 and 2023. BACTEC 460 TB, BACTEC MGIT 960 culture systems and L\u00f6wenstein\u2013Jensen medium were used for the culture of these samples. The susceptibility of M. tuberculosis complex strains grown in culture to isoniazid (INH) (0.1 \u03bcg\/mL), rifampicin (RIF) (1.0 \u03bcg\/mL), ethambutol (ETB) (5.0 \u03bcg\/mL) and streptomycin (SM) (1.0 \u03bcg\/mL) antibiotics was studied according to the manufacturer\u2019s recommendation. Results: Out of 104,598 patient samples, 2752 (2.6%) were culture-positive, and the susceptibility test results of 1869 of these were analyzed. Of the isolates, 358 (19.2%) were found to be resistant to at least one first-line drug, i.e., INH, RIF, ETB, or SM. In addition, 2.9% were resistant to two or more first-line drugs. Conclusions: Drug susceptibility testing is essential to ensure the optimal treatment and control of drug-resistant TB strains. This study highlights the value of ongoing efforts to control tuberculosis drug resistance in the fight against this disease.<\/jats:p>","DOI":"10.3390\/medicina61061060","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:54:05Z","timestamp":1749448445000},"page":"1060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resistance Rates of Mycobacterium tuberculosis Complex Strains: A Retrospective Study in T\u00fcrkiye"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1725-0644","authenticated-orcid":false,"given":"Melda","family":"Payasl\u0131o\u011flu","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uluda\u011f University, Bursa 16000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-4989","authenticated-orcid":false,"given":"\u0130mran","family":"Sa\u011fl\u0131k","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uluda\u011f University, Bursa 16000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00fcneyt","family":"\u00d6zak\u0131n","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Bursa Uluda\u011f University, Bursa 16000, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2020). Global Tuberculosis Control: World Health Organization Report 2019 WHO\/HTM\/TB\/2019, World Health Organization."},{"key":"ref_2","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u201312265."},{"key":"ref_3","unstructured":"World Health Organization (WHO) (2025, April 20). Global Tuberculosis Report, Geneva. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"American Thoracic Society and the Centers for Disease Control and Prevention (2000). Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Resp. Crit. Care Med., 161, 1376\u20131395.","DOI":"10.1164\/ajrccm.161.4.16141"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2478\/s11536-010-0011-z","article-title":"Genitourinary tuberculosis in a 54-year-old woman: Diagnostic difficulty","volume":"5","author":"Agca","year":"2010","journal-title":"Open Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin","volume":"328","author":"Goble","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"1320","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis","volume":"13","author":"Zhang","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235190","DOI":"10.1155\/2013\/235190","article-title":"Drug resistance among pulmonary tuberculosis patients in Calabar, Nigeria","volume":"2013","author":"Otu","year":"2013","journal-title":"Pulm. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: A systematic review","volume":"61","author":"Faustini","year":"2006","journal-title":"Thorax"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Suchindran, S., Brouwer, E.S., and Van Rie, A. (2009). Is HIV infection a risk factor for multi-drug resistant tuberculosis?. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005561"},{"key":"ref_11","first-page":"382","article-title":"Multi-drug resistant tuberculosis: Epidemiology, risk factors and case finding","volume":"14","author":"Caminero","year":"2010","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: An action framework for low-incidence countries","volume":"45","author":"Migliori","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_13","unstructured":"Republic of Turkey Ministry of Health, General Directorate of Public Health (2019). Diagnostic and Therapeutic Guide."},{"key":"ref_14","unstructured":"Republic of Turkey Ministry of Health, General Directorate of Public Health (2018). 2018 Report on the Fight Against Tuberculosis in Turkey."},{"key":"ref_15","unstructured":"Republic of Turkey Ministry of Health, General Directorate of Public Health (2016). Tuberculosis Fight in Turkey 2016 Report."},{"key":"ref_16","unstructured":"Republic of Turkey Ministry of Health, General Directorate of Public Health (2015). Tuberculosis Fight in Turkey 2015 Report."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jinf.2004.05.010","article-title":"Drug resistance of Mycobacterium tuberculosis in western Turkey: A retrospective study from 1100-bed teaching hospital","volume":"50","author":"Senol","year":"2005","journal-title":"J. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5144\/0256-4947.2005.313","article-title":"Drug-resistant pulmonary tuberculosis in western Turkey: Prevalence, clinical characteristics and treatment outcome","volume":"25","author":"Surucuoglu","year":"2005","journal-title":"Ann. Saudi Med."},{"key":"ref_19","first-page":"403","article-title":"Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs","volume":"41","author":"Ocak","year":"2007","journal-title":"Mikrobiyol. Bui."},{"key":"ref_20","first-page":"174","article-title":"Investigation of combined drug resistance in Mycobacterium tuberculosis strains using the BACTEC method","volume":"8","author":"Saral","year":"2007","journal-title":"Tur. Toraks Der."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jiph.2013.02.005","article-title":"drug resistance in pulmonary tuberculosis in new and previously treated cases: Experience from Turkey","volume":"6","author":"Komurcuoglu","year":"2013","journal-title":"J. Infect. Public Health"},{"key":"ref_22","first-page":"71","article-title":"Aktif akci\u011fer t\u00fcberk\u00fclozlu hastalardan izole edilen Mycobacterium tuberculosis k\u00f6kenlerinin ila\u00e7 diren\u00e7 oranlar\u0131n\u0131n de\u011ferlendirilmesi","volume":"9","author":"Erer","year":"2006","journal-title":"Klimik Dergisi."},{"key":"ref_23","first-page":"23","article-title":"Mycobacterium tuberculosis su\u015flar\u0131n\u0131n antit\u00fcberk\u00fcloz ila\u00e7lara direnci: Trakya \u00dcniversitesi Hastanesi\u2019nin iki y\u0131ll\u0131k sonu\u00e7lar\u0131 (Resistance of Mycobacterium tuberculosis strains to antituberculosis drugs: Two-year results of Trakya University Hospital.)","volume":"17","author":"Tansel","year":"2003","journal-title":"Infeksiyon Derg."},{"key":"ref_24","first-page":"47","article-title":"The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey","volume":"58","author":"Ozturk","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1128\/JCM.01308-07","article-title":"Population-based molecular epidemiological study of tuberculosis in Malatya, Turkey","volume":"45","author":"Durmaz","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","first-page":"171","article-title":"Antituberculosis drug resistance and associated risk factors in the European section of Turkey","volume":"46","author":"Karabay","year":"2004","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"ref_27","first-page":"459","article-title":"Resistance rates to antituberculous drugs in Sivas province","volume":"41","author":"Bakici","year":"2007","journal-title":"Mikrobiyol. Bul."},{"key":"ref_28","first-page":"75","article-title":"Comparison of BACTEC 460 and A\u011far Proportion methods in determining the sensitivity of Mycobacterium tuberculosis strains to primary antituberculosis drugs","volume":"21","author":"Aslan","year":"2007","journal-title":"Infeksiyon Derg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.16899\/jcm.841505","article-title":"Investigation of the sensitivity of Mycobacterium tuberculosis strains isolated from various clinical samples in Eastern Turkey to major anti-tuberculosis drugs","volume":"11","year":"2021","journal-title":"J. Contemp. Med."},{"key":"ref_30","first-page":"559","article-title":"Analysis of Mycobacterium tuberculosis Culture and Drug Susceptibility Test Results Isolated from Clinical Samples and Investigation of the Distribution of Non-Tuberculosis Mycobacteria","volume":"54","year":"2020","journal-title":"Mikrobiyol. Bul."},{"key":"ref_31","first-page":"53","article-title":"Resistance rates of primary anti-tuberculosis drugs of Mycobacterium tuberculosis complex, which is isolated in the Erzurum Regional Tuberculosis Laboratory","volume":"31","author":"Aslan","year":"2017","journal-title":"ANKEM Derg."},{"key":"ref_32","first-page":"2304","article-title":"Primary resistance rates of Mycobacterium tuberculosis complex strains isolated from new tuberculosis cases: A 6-year observation","volume":"5","author":"Kayhan","year":"2011","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/tmsj.2018.05.02.0002","article-title":"Resistance rates of Mycobacterium tuberculosis complex isolates obtained from clinical samples to major antituberculous drugs: A study in Edirne, Turkey","volume":"5","year":"2018","journal-title":"Turk. Med Stud. J."},{"key":"ref_34","first-page":"92","article-title":"First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey","volume":"67","year":"2019","journal-title":"Tuberk. Toraks."},{"key":"ref_35","first-page":"177","article-title":"Susceptibilities of Mycobacterium tuberculosis complex isolates to first-line antituberculosis drugs in Eski\u015fehir, Turkey","volume":"16","author":"Arslan","year":"2015","journal-title":"T\u00fcrk. Toraks Dergisi."},{"key":"ref_36","first-page":"53","article-title":"Retrospektif olarak t\u00fcberk\u00fcloz laboratuvar\u0131n\u0131n alt\u0131 y\u0131ll\u0131k sonu\u00e7lar\u0131 ve antimikrobiyal ila\u00e7lara diren\u00e7 oranlar\u0131 (Retrospective six-year tuberculosis laboratory results and antimicrobial drug resistance rates)","volume":"14","author":"Demirbilek","year":"2013","journal-title":"Turk. Toraks Derg."},{"key":"ref_37","first-page":"1","article-title":"Mycobacterium tuberculosis kompleksi su\u015flar\u0131nda duyarl\u0131l\u0131k oranlar\u0131 (Susceptibility rates in Mycobacterium tuberculosis complex strains)","volume":"33","author":"Karahasan","year":"2019","journal-title":"ANKEM Derg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.26453\/otjhs.441168","article-title":"M. tuberculosis kompleks izolatlar\u0131n\u0131n anti-t\u00fcberk\u00fcloz ila\u00e7lara diren\u00e7 oranlar\u0131nda y\u0131llara g\u00f6re de\u011fi\u015fim (Changes in resistance rates of M. tuberculosis complex isolates to anti-tuberculosis drugs over the years)","volume":"4","author":"Terzi","year":"2019","journal-title":"Sak. Online T\u00fcrk. Sa\u011fl\u0131k Bilim. Derg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.35232\/estudamhsd.524166","article-title":"Akci\u011fer t\u00fcberk\u00fclozlu olgulardan izole edilen Mycobacterium tuberculosis izolatlar\u0131nda primer t\u00fcberk\u00fcloz ila\u00e7 direncinin ara\u015ft\u0131r\u0131lmas\u0131 (Investigation of primary tuberculosis drug resistance in Mycobacterium tuberculosis isolates from pulmonary tuberculosis cases)","volume":"4","author":"Aksu","year":"2019","journal-title":"EST\u00dcDAM Halk Sa\u011fl\u0131\u011f\u0131 Derg."},{"key":"ref_40","first-page":"117","article-title":"Akci\u011fer t\u00fcberk\u00fclozu olan 232 yeni olgunun retrospektif olarak de\u011ferlendirilmesi (Retrospective evaluation of 232 new cases with pulmonary tuberculosis)","volume":"48","author":"Etiz","year":"2018","journal-title":"Turk. Mikrobiyol. Cemiy. Derg."},{"key":"ref_41","first-page":"2175","article-title":"Susceptibility of first-line antituberculosis drugs in Southeastern Turkey","volume":"3","author":"Ezin","year":"2016","journal-title":"Int. J. Med. Sci. Clin. Invent."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5505\/ejm.2019.49368","article-title":"Tuberculosis cases in Mardin between 2012 and 2018","volume":"24","author":"Kabak","year":"2019","journal-title":"East J. Med."},{"key":"ref_43","unstructured":"Republic of Turkey Ministry of Health, General Directorate of Public Health (2021). Tuberculosis Fight in Turkey 2021 Report."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:48:48Z","timestamp":1760032128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061060"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061060","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,6,9]]}}}